AR025791A1 - Forma de dosificacion oral - Google Patents

Forma de dosificacion oral

Info

Publication number
AR025791A1
AR025791A1 ARP000105062A ARP000105062A AR025791A1 AR 025791 A1 AR025791 A1 AR 025791A1 AR P000105062 A ARP000105062 A AR P000105062A AR P000105062 A ARP000105062 A AR P000105062A AR 025791 A1 AR025791 A1 AR 025791A1
Authority
AR
Argentina
Prior art keywords
dosage form
oral dosage
deunion
disintegrant
saccharide
Prior art date
Application number
ARP000105062A
Other languages
English (en)
Original Assignee
Alkaloid Ad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9925069A external-priority patent/GB2355406A/en
Priority claimed from GB0014497A external-priority patent/GB0014497D0/en
Application filed by Alkaloid Ad filed Critical Alkaloid Ad
Publication of AR025791A1 publication Critical patent/AR025791A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una forma de dosificacion solida sublingual farmacéutica que comprende una sal de morfina junto con excipientes que incluyen un sacárido, un agente deunion y un desintegrante. También se describe un método de preparacion de la forma de dosificacion,junto con un empaquetado adecuado para el almacenamientopor largo tiempo de la forma de dosificacion.
ARP000105062A 1999-10-23 2000-09-27 Forma de dosificacion oral AR025791A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9925069A GB2355406A (en) 1999-10-23 1999-10-23 A sub-lingual dosage form comprising a morphine salt
GB0014497A GB0014497D0 (en) 2000-06-15 2000-06-15 Oral dosage form

Publications (1)

Publication Number Publication Date
AR025791A1 true AR025791A1 (es) 2002-12-11

Family

ID=26244484

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105062A AR025791A1 (es) 1999-10-23 2000-09-27 Forma de dosificacion oral

Country Status (7)

Country Link
EP (1) EP1221944A1 (es)
AR (1) AR025791A1 (es)
AU (1) AU7023200A (es)
CA (1) CA2388123A1 (es)
PL (1) PL354872A1 (es)
RU (1) RU2002110329A (es)
WO (1) WO2001030321A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2450117A (en) * 2007-06-13 2008-12-17 Reckitt Benckiser Healthcare A water- and oxygen-occlusive blister tablet pack
EP2970320B1 (en) * 2013-03-15 2020-10-28 Johnson Matthey Public Limited Company Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3263555D1 (en) * 1981-11-23 1985-06-20 Hoffmann La Roche Analgesic compositions containing an opiate alkaloid compound and a carbazole compound
US5580876A (en) * 1992-09-21 1996-12-03 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
CA2144538C (en) * 1992-09-30 2003-12-23 Andrew Roy Thompson Stepped-edge blister pack and use of steps
US5811126A (en) * 1995-10-02 1998-09-22 Euro-Celtique, S.A. Controlled release matrix for pharmaceuticals
DE19749724A1 (de) * 1997-11-11 1999-06-10 Gruenenthal Gmbh Verwendung einer Kombination aus Opioid und alpha-adrenergem Agonisten in Schmerzmitteln

Also Published As

Publication number Publication date
CA2388123A1 (en) 2001-05-03
WO2001030321A1 (en) 2001-05-03
RU2002110329A (ru) 2003-11-20
PL354872A1 (en) 2004-03-08
EP1221944A1 (en) 2002-07-17
AU7023200A (en) 2001-05-08

Similar Documents

Publication Publication Date Title
ES2157297T3 (es) Granulos entericos de duloxetina.
NO2013004I1 (no) axitinib, valgfritt i form av et farmasøytisk aksentabelt salt
ES2191682T3 (es) Nueva formulacion farmaceutica.
NO2015026I2 (no) panobinostat eller et farmasøytisk akseptabelt salt derav
MA26800A1 (fr) Systemes et methodes aerosoles pour formulations pharmaceutiques.
GEP20074047B (en) Pramipexole once-daily dosage form
NO20031694L (no) Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
NO20032438L (no) Ortosubstituerte og metasubstituerte bisarylforbindelser, fremgangsmåte forfremstilling derav, deres anvendelse som et medikament samtfarmasöytiske preparater inneholdende forbindelsene
ES2172239T3 (es) Sistema osmotico de liberacion de farmacos.
NO993520L (no) Doseringsformer og fremgangsmÕte for Õ bedre erektil dysfunksjon
AR040054A1 (es) Envoltura externa para un recipiente de liberacion controlada, recipiente de liberacion controlada y metodo para la produccion de un recipiente de liberacion controlada.
LU92366I2 (fr) Teriflunomide, son stéréoisomère et leurs sels pharmaceutiquement acceptables
NZ320545A (en) Injectable quinolone formulations
UY25544A1 (es) Forma de dosificación de nefazodona
AR026968A1 (es) Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral
ECSP066338A (es) Nueva composición que comprende rosiglitazona y otro agente antidiabético
MY119722A (en) Swallow tablet comprising paracetamol.
AR003476A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
AR025791A1 (es) Forma de dosificacion oral
IT1302063B1 (it) Dispositivo di sopporto anti-panico per una tavoletta di sedia, esedia comprendente tale dispositivo.
AR020205A1 (es) Formulacion efervescente esterilizante.
MX9203735A (es) Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso.
BR0016655B1 (pt) método para liberar um agente de benefìcio.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal